Alex has worked in corporate finance, life sciences and healthcare, and principal investing since 2003. He has worked at THP since 2009. He has represented THP on the boards of Argonaut Manufacturing Services, Carterra, Cell Microsystems, Dynex Technologies, Excellos and Teknova (NASDAQ:TKNO). He was a board observer at Agena Bioscience (acquired by Mesa Laboratories). In 2021, he moved to North Carolina from San Francisco to open THP’s Research Triangle office.  Prior to joining THP, Alex worked in Business Development in the Oncology/Multiple Sclerosis Group at Genzyme Corporation. At Genzyme, he structured licensing and M&A transactions in the biotechnology and pharmaceuticals space. He has also worked as a Portfolio Manager at BlueMountain Capital Management and as an Analyst in Investment Banking at Bank of America Securities. Alex holds an MBA with honors from Kellogg School of Management at Northwestern University and a Bachelor of Science in Economics with a Minor in Molecular and Cellular Biology from Duke University.